NRC vs. SLP, DH, ELVN, TNGX, ETNB, AORT, ARQT, VRDN, USNA, and AVNS
Should you be buying National Research stock or one of its competitors? The main competitors of National Research include Simulations Plus (SLP), Definitive Healthcare (DH), Enliven Therapeutics (ELVN), Tango Therapeutics (TNGX), 89bio (ETNB), Artivion (AORT), Arcutis Biotherapeutics (ARQT), Viridian Therapeutics (VRDN), USANA Health Sciences (USNA), and Avanos Medical (AVNS).
National Research (NASDAQ:NRC) and Simulations Plus (NASDAQ:SLP) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, community ranking, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.
National Research pays an annual dividend of $0.48 per share and has a dividend yield of 1.7%. Simulations Plus pays an annual dividend of $0.24 per share and has a dividend yield of 0.5%. National Research pays out 38.7% of its earnings in the form of a dividend. Simulations Plus pays out 45.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. National Research is clearly the better dividend stock, given its higher yield and lower payout ratio.
In the previous week, National Research had 7 more articles in the media than Simulations Plus. MarketBeat recorded 11 mentions for National Research and 4 mentions for Simulations Plus. Simulations Plus' average media sentiment score of 0.67 beat National Research's score of 0.23 indicating that Simulations Plus is being referred to more favorably in the news media.
National Research has higher revenue and earnings than Simulations Plus. National Research is trading at a lower price-to-earnings ratio than Simulations Plus, indicating that it is currently the more affordable of the two stocks.
Simulations Plus received 161 more outperform votes than National Research when rated by MarketBeat users. Likewise, 62.82% of users gave Simulations Plus an outperform vote while only 61.67% of users gave National Research an outperform vote.
47.3% of National Research shares are held by institutional investors. Comparatively, 78.1% of Simulations Plus shares are held by institutional investors. 2.0% of National Research shares are held by company insiders. Comparatively, 20.9% of Simulations Plus shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
National Research has a beta of 0.45, meaning that its stock price is 55% less volatile than the S&P 500. Comparatively, Simulations Plus has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500.
Simulations Plus has a consensus price target of $51.00, indicating a potential upside of 5.50%. Given Simulations Plus' higher possible upside, analysts plainly believe Simulations Plus is more favorable than National Research.
National Research has a net margin of 20.84% compared to Simulations Plus' net margin of 16.22%. National Research's return on equity of 47.79% beat Simulations Plus' return on equity.
Summary
Simulations Plus beats National Research on 10 of the 19 factors compared between the two stocks.
Get National Research News Delivered to You Automatically
Sign up to receive the latest news and ratings for NRC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
National Research Competitors List
Related Companies and Tools
